Minimal residual disease, or MRD, testing can offer psychological comfort to patients with breast cancer and survivors as well as insight into potential treatment strategies for care providers, as an ...

Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone of treatment, with excellent outcomes in many cases. Patients are ...

Smoldering multiple myeloma is an asymptomatic, precancerous condition with abnormal plasma cells and elevated monoclonal protein levels. Smoldering multiple myeloma is a complex, intermediary stage ...

Stage 1 lung carcinoid tumors are confined to the lung and have not spread to lymph nodes or distant organs. Tumors at this stage are typically small and localized, which often allows for curative ...

Minimal residual disease testing can offer psychological comfort to patients and survivors as well as insight into potential treatment strategies for care providers.

This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...

Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...

Obeid emphasized that risk assessment is a critical part of ongoing cancer care. It helps patients and their families understand the cancer’s causes, informs treatment options and supports strategies ...

The transition to a survivorship program evokes complex emotions, including excitement, hesitation, and survivor's guilt, as ...

Despite its popularity, biotin lacks strong evidence for hair regrowth, and safer alternatives like minoxidil are recommended ...

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.